Exploring Key Insights of the Point-of-Care (POC) Coagulation Testing Devices Market: Growth Prospects, Emerging Trends, and Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the point-of-care (poc) coagulation testing devices market?
The market size of point-of-care (POC) coagulation testing devices has seen robust growth in recent times. The market size, which stood at $2.12 billion in 2024, is projected to reach $2.33 billion in 2025. This represents a compound annual growth rate (CAGR) of 9.9%. Factors such as an increase in infectious and chronic diseases, a larger aging population, higher usage of compact portable instruments, a growing trend in the use of biomarker profiling, and an escalating demand for personalized medicine all contribute to the historical growth rate.
What will be the point-of-care (poc) coagulation testing devices market size in the future?
In the years to come, the market for point-of-care (POC) coagulation testing devices is projected to experience significant growth, reaching a value of $3.36 billion in 2029 with a compound annual growth rate (CAGR) of 9.7%. This growth during the forecast period can be ascribed to an increase in the necessity for speedy and precise disease diagnoses, a heightened focus on wellness and preventive healthcare, the escalating demand for quick and onsite diagnostic testing, a surge in infectious disease occurrences, and the evolution of telemedicine. Noteworthy trends expected in the forecast period encompass next-generation sequencing (NGS) integration, RNA detection and analysis, single-cell PCR examinations, bioinformatics software and data analysis tools, microfluidic technologies, lab-on-a-chip mechanisms, and point-of-care testing (POCT), in addition to the rise of artificial intelligence (AI) and data analytics.
Get your point-of-care (poc) coagulation testing devices market report here!
What main drivers are fueling expansion in the point-of-care (poc) coagulation testing devices market?
The increase in blood clotting disorders is projected to fuel the expansion of the point-of-care (POC) coagulation testing devices market. Blood clotting disorders can impede the proper coagulation of blood. Unhealthy lifestyle behaviors, such as smoking, excessive drinking, and lack of physical activity can lead to these disorders by affecting the health of blood vessels, clotting factor levels, and blood circulation, enhancing the possibility of irregular clot formation. POC coagulation testing devices provide healthcare professionals the ability to swiftly evaluate a patient’s coagulation status, facilitating prompt modifications to medication doses and treatment strategies. For instance, as per the yearly global survey carried out by the World Federation of Hemophilia, a non-profit organization located in Canada, the record of 2022 states 427,685 individuals had bleeding disorders, and 257,146 individuals were diagnosed with hemophilia which includes 208,957 with Hemophilia A, 42,203 with Hemophilia B, and 5,986 with an unidentified type of hemophilia. Plus, another 70,034 individuals suffer from different types of bleeding disorders. Hence, the increasing prevalence of blood clotting disorders is propelling the growth of the point-of-care (POC) coagulation testing devices market.
What key areas define the segmentation of the global point-of-care (poc) coagulation testing devices market?
The point-of-care (POC) coagulation testing devices market covered in this report is segmented –
1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Blood Gas And Electrolyte Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users
Subsegments:
1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors
2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles
3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15636&type=smp
Who are the dominant players expanding their reach in the point-of-care (poc) coagulation testing devices market?
Major companies operating in the point-of-care (POC) coagulation testing devices market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips N.V., Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, Sonora Quest Laboratories, 23andMe Holding Co, Thorne HealthTech Inc., Metropolis Healthcare Limited, Color Health Inc., LetsGetChecked Inc., Ambry Genetics Corporation, MyHeritage Ltd., Genova Diagnostics Inc., Everlywell Inc., Complete Genomics Incorporated, DanteLabs Inc., HemoSonics LLC, Gene by Gene Ltd., Veritas Intercontinental, DirectLabs LLC, Full Genomes Corporation Inc., Ulta Lab Tests LLC, WellnessFX Inc., Any Lab Test Now Inc.
What are the key trends shaping the future of the point-of-care (poc) coagulation testing devices market?
Leading firms in the point-of-care (POC) coagulation testing devices industry are advancing the diagnosis and management of coagulation malfunctions by producing immunofluorescence-based quantitative analyzers. These diagnostic tools are utilized in labs to gauge and quantify the particular proteins or molecules necessary for the clotting process, eventually aiding in the diagnosis and management of blood clotting abnormalities. To illustrate, in January 2023, Cipla Limited, a Pharmaceutical firm based in India, unveiled Cippoint. This is an immunofluorescence-based quantitative analyzer that employs immunofluorescence technology to deliver swift and precise test outcomes in a range between 3 to 15 minutes, thereby streamlining clinical decision-making. Its user-friendly interface, quick response time, and wide testing capabilities make Cippoint instrumental in boosting diagnostic effectiveness, speeding up medical decisions, and enhancing patients’ healthcare results.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15636
Which regions are emerging as leaders in the point-of-care (poc) coagulation testing devices market?
North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2024. The regions covered in the point-of-care (POC) coagulation testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
IoT Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/iot-testing-global-market-report
Non-Animal Alternatives Testing Global Market Report 2024
Hospital Acquired Infections Testing Kits Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
